New combo for colorectal cancer shows promise but trial ends early
Disease control
Terminated
This study tested a new drug combination (NUFIRI-bev) against a standard treatment (FOLFIRI-bev) for people with advanced colorectal cancer that had already been treated. The goal was to see if the new combo worked better at controlling the cancer. The trial was stopped early, so…
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated May 14, 2026 12:04 UTC